The FDA has approved Merck's (MRK -0.2%) Liptruzet drug for treating elevated LDL cholesterol...

|About: Merck & Co Inc. (MRK)|By:, SA News Editor

The FDA has approved Merck's (MRK -0.2%) Liptruzet drug for treating elevated LDL cholesterol levels in patients with primary or mixed hyperlipidemia. Lipruzet combines two existing anti-cholesterol drugs, ezetimibe and atorvastatin. It'll be available to wholesalers next week. (PR)